Vitamins and mineralsStudies updated this monthHigh-dose vitamin C—a medicine you won't hear about at the doctor's office?
What do Natural Therapy Specialists write?
For a life-threatening infection, Andrzej Frydrychowski recommends intravenous doses of 40 to 200 g of vitamin C per day and claims that this kind of administration is prohibited.
High doses of vitamin C were presented as possible support in severe viral respiratory infections.
High-dose vitamin C was presented as possible immune support that may limit complications and shorten the course of a viral infection.
During an infection, Andrzej Frydrychowski recommends 2 g of vitamin C every three hours and intravenous administration in life-threatening situations.
High intravenous doses were described as promising for treating COVID-19, but it was also noted that vitamin C does not cure.
For kidney problems, Jerzy Zięba recommends using vitamin C cautiously and slowly, preferably under a doctor's supervision.
Andrzej Frydrychowski cites claims about intravenous vitamin C being used to treat several infections, including a 1 g dose for malaria.
Intravenous vitamin C given together with chemotherapy to nine patients was described as a treatment for advanced pancreatic cancer.
What does scientific research from PubMed · Europe PMC say?
We selected 9 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 2 621.
Aim of the study: Acute respiratory tract infections (ARIs) are a leading cause of ill-health and death globally. Individual or multiple micronutrients have been shown to modulate immune function and affect the risk and severity of a number of infectious diseases.
Results: The effect of vitamin C on preventing ARI was stronger among men and in middle-income countries, compared with women and high-income countries, respectively. Zinc supplementation did not reduce the risk of ARIs but shortened the duration of symptoms substantially (per cent difference: -47% (95% CI -73% to -21%; p=0.0004)). Our synthesis of global evidence from randomised controlled trials indicates that micronutrient supplements including zinc, vitamins C and D, and multiple micronutrient supplements may be modestly effective in preventing ARIs and improving their clinical course. Further research is warranted to better understand the effectiveness that individual or multiple micronutrients have on SARS-CoV-2 infection and treatment outcomes.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Vitamin C (VitC) is known to directly impair cancer cell growth in preclinical models, but there is little clinical evidence on its antitumoral efficacy. In addition, whether and how VitC modulates anticancer immune responses is mostly unknown.
Results: High-dose VitC modulates infiltration of the tumor microenvironment by cells of the immune system and delays cancer growth in a T cell-dependent manner. VitC not only enhances the cytotoxic activity of adoptively transferred CD8 T cells but also cooperates with immune checkpoint therapy (ICT) in several cancer types. Combination of VitC and ICT can be curative in models of mismatch repair-deficient tumors with high mutational burden. This work provides a rationale for clinical trials combining ICT with high doses of VitC.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Tendinopathy is an aging-related disease, often caused by micro-scarring and degeneration due to overuse or trauma. Ascorbic acid (vitamin C) supplementation is reported to be a useful treatment for tendinopathy recovery.
Results: The cytoskeleton was maintained in the HC group but not in the C group. qPCR analysis revealed that p16 expression was inhibited in both the C and HC groups compared to the H2O2 group; other markers had increased expression. The progression of cell death and cytoskeletal disruption was inhibited by the administration of high-dose vitamin C. Hence, high-dose vitamin C is a potential treatment for tendon cell degeneration.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Radiation-induced pulmonary fibrosis (RIPF) is a frequently encountered late complication in patients undergoing radiation therapy, presenting a substantial risk to patient mortality and quality of life. The pathogenesis of RIPF remains unclear, and current treatment options are limited in efficacy.
Results: In order to explore the mechanism by which high-dose vitamin C attenuates RIPF, we utilized RNA-seq analysis of mouse lung tissue in conjunction with publicly available databases. Our findings indicated that high-dose vitamin C inhibits the differentiation of fibroblasts into myofibroblasts by targeting S100A8 and S100A9 derived from neutrophils. Additionally, the combination of high-dose vitamin C and radiation demonstrated enhanced inhibition of tumor growth in a murine LLC tumor model. These results revealed that the combination of radiotherapy and high-dose vitamin C may offer a promising therapeutic approach for the clinical management of thoracic tumors and the prevention of RIPF.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Acute kidney injury frequently occurs after cardiac surgery, and is primarily attributed to renal ischemia-reperfusion (I/R) injury and inflammation from surgery and cardiopulmonary bypass. Vitamin C, an antioxidant that is often depleted in critically ill patients, could potentially mitigate I/R-induced oxidative stress at high doses.
Results: Doses of 100 and 200 mg/kg during reperfusion reduced oxidative stress markers, including myeloperoxidase and inflammatory responses by decreasing high mobility group box 1 release and nucleotide-binding and oligomerization domain-like receptor 3 inflammasome. Overall beneficial effect was most prominent with 200 mg/kg. The 300 mg/kg dose, however, showed no additional benefits over the IRC group regarding serum blood urea nitrogen and creatinine levels and histological evaluation. During reperfusion, high-dose vitamin C administration (200 mg/kg) significantly decreased renal I/R injury by effectively attenuating the major triggers of oxidative stress and inflammation.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: KRAS mutations are frequently observed in human cancer and are associated with proliferation, therapy-resistance and worse outcome. Regrettably, only a fraction of possible mutations is druggable.
Results: Obviously we do not know whether this response could have also been observed if chemotherapy was given w/o high-dose vitamin C. As up to now two randomized clinical trials showed a beneficial effect of the addition of high-dose vitamin C (pancreatic cancer: Bodeker et al., colorectal cancer: Vitality trial), and, in the case of Vitality, the benefit was restricted to KRAS mutated tumors only, more clinical trials addressing this topic are needed. Therefore, we thank Bodeker et al. for contributing these important data.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: The adjunctive therapeutic value of vitamin C in sepsis or septic shock patients remains controversial. This study aimed to evaluate the therapeutic efficacy and safety of intravenous administration of vitamin C in sepsis or septic shock patients through meta-analysis.
Results: Fourteen randomized controlled trials enrolling 1,958 patients were eligible for assessment. Meta-analysis demonstrated that intravenous vitamin C reduced 28-day mortality in sepsis or septic shock patients compared to the control group (RR 0.70; 95% CI 0.53 to 0.93; P = 0.02; I 2 = 52%), based on low quality of evidence, and subgroup analysis showed the benefit was driven by single-center studies, not observed in multicenter trials. Vitamin C shortened the duration of vasopressor use (SMD = -0.42, 95% CI -0.77 to -0.08, P = 0.02) and was associated with a greater reduction in SOFA score (MD = -1.04, 95% CI -1.83 to -0.25, P = 0.01), but did not reduce vasopressor dose, length of stay, or 24-h urine output. No significant adverse events were reported. This meta-analysis suggests that intravenous vitamin C might be associated with reduced mortality in sepsis, but the benefit was not confirmed in low-risk-of-bias multicenter trials and was primarily driven by single-center studies.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Background: High-dose intravenous vitamin C (IVC) and mistletoe therapy are widely used in palliative care as complementary interventions to relieve symptoms and improve quality of life. However, prospective evidence regarding their impact on overall survival in breast cancer remains limited.
Results: In multivariable time-dependent Cox regression analysis, high-dose IVC therapy (HR: 0.561, 95% CI: 0.319-0.986, p = 0.045) and mistletoe therapy (HR: 0.463, 95% CI: 0.231-0.927, p = 0.030) were independently associated with significantly reduced overall mortality risk. Hyperthermia therapy showed no significant association with mortality after multivariable adjustment (HR: 1.497, 95% CI: 0.794-2.820, p = 0.212). Conclusions: High-dose IVC and mistletoe therapies were independently associated with lower overall mortality in female breast cancer patients. These findings support further investigation of these modalities as potential integrative adjuncts to standard care.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: High-dose vitamin C (vitC) has shown superior anticancer activity in immunocompetent compared with immunodeficient mice, suggesting an immunodependent mechanism of action.
Results: This was accompanied by substantial remodeling of the tumor microenvironment, including increased infiltration of cytotoxic CD8⁺ T cells and natural killer cells, and a reduction in immunosuppressive regulatory T cells. Blocking calreticulin effectively disrupted the ICD cascade, prevented immune microenvironment remodeling, and completely abrogated the antitumor efficacy of vitC. Collectively, our study indicates that high-dose vitC promotes ICD by mobilizing calreticulin and HMGB1, and that calreticulin is a determinant of its immune-mediated antitumor activity. Implications: vitC induces ICD, supporting its use as an adjuvant to anticancer immunotherapy.
“Not stated” does not mean nobody paid — the database does not always record it.
What do orthomolecular medicine doctors write?
Sources (16)
- Andrzej Frydrychowski — Witamina C w postaci liposomalnej
- Jerzy Zięba — Przegląd doniesień na temat witaminy C Jerzy Zięba
- Jerzy Zięba — C – witamina ciężkiej wagi
- Andrzej Frydrychowski — Czego jeszcze nie wiemy o witaminie C? Część 3
- Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. · BMJ Glob Health 2021
- High-dose vitamin C enhances cancer immunotherapy. · Sci Transl Med 2020
- Effect of High-Dose Vitamin C on Tendon Cell Degeneration-An In Vitro Study. · Int J Mol Sci 2024
- High-dose vitamin C attenuates radiation-induced pulmonary fibrosis by targeting S100A8 and S100A9. · Biochim Biophys Acta Mol Basis Dis 2024
- Effect of high-dose vitamin C on renal ischemia-reperfusion injury. · Biomed Pharmacother 2024
- High-dose vitamin C as a targeted treatment for KRAS-driven cancers? · Redox Biol 2025
- Intravenous vitamin C as micronutrient therapy in patients with sepsis or septic shock: an updated systematic review and meta-analysis of randomized controlled trials. · Front Nutr 2026
- High-Dose Intravenous Vitamin C and Mistletoe Therapy in Breast Cancer: A Prospective Cohort Study on Overall Survival in Palliative Care. · Cancers (Basel) 2026
- Calreticulin exposure is a critical mediator of high-dose vitamin C-induced immune surveillance in the tumor microenvironment. · Mol Cancer Res 2026
- Orthomolecular Medicine News Service — Published Research and Articles on Vitamin C as a Consideration for Pneumonia, Lung Infections, and the Novel Coronavirus (SARS-CoV-2/COVID-19)
- Orthomolecular Medicine News Service — Rationale for Vitamin C Treatment of COVID-19 and Other Viruses
- Orthomolecular Medicine News Service — World-Wide Nutritional Immunity - Why everybody, everywhere is taking vitamin C
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.